Skip to content
Trial Eligibility
Menu

B-Complex: A Nutraceutical SANS Countermeasure

NCT05366933

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

In this project, the investigators propose to test effectiveness of a daily nutraceutical supplement containing bioactive B vitamins to mitigate optic disc edema in astronauts. The proposed countermeasure is intended to maximize functioning of the one-carbon metabolic pathway to provide enough substrate and cofactors to overcome any genetic differences that may impact the efficiency of enzyme function.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Optic Disc Edema
  • Endothelial Dysfunction

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
20 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Aeronautics and Space Administration (NASA)
Last updated on ClinicalTrials.gov
May 22, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • Johnson Space Center · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.